Boston Scientific announces agreement to acquire NxThera
Boston Scientific announced it has entered into a definitive agreement to acquire NxThera, a privately-held company based in Maple Grove, Minnesota. The transaction consists of an upfront cash payment of $306 million, and up to an additional $100 million in potential commercial milestone payments. March 21, 2018